期刊文献+

河南省不同级别医院急性ST段抬高型心肌梗死患者早期再灌注治疗现状调查 被引量:21

Survey on the early reperfusion therapy status in patients with ST-segment elevation myocardial infarction hospitalized in tertiary and secondary hospitals in Henan province
原文传递
导出
摘要 目的 了解河南省不同级别医院急性ST段抬高型心肌梗死(STEMI)患者的早期再灌注治疗现状.方法 采用统一调查表,对2011年6月至2012年6月河南省17家医院(8家三级医院,9家二级医院)的STEMI患者进行登记,收集基线资料、早期再灌注治疗情况和住院病死率等资料.结果 共入选1 686例STEMI患者,其中886例患者来自三级医院,800例患者来自二级医院.654例患者接受早期再灌注治疗,其中83.0%(543/654)患者接受溶栓治疗,17.0%(111/654)患者接受直接经皮冠状动脉介入治疗(PCI).三级和二级医院STEMI患者的早期再灌注比例差异无统计学意义[40.1% (355/886)比37.4% (299/800),P=0.257].发病-接诊、入门-溶栓和入门-球囊扩张时间中位数分别为132、18和60 min.三级医院STEMI患者的发病-接诊(150 min比120 min,P=0.001)、入门-溶栓(30 min比18 min,P=0.003)及发病-溶栓(3.5h比2.7h,P=0.001)时间中位数均长于二级医院,而不同级别医院患者的入门-球囊扩张、发病-直接PCI和发病-择期PCI时间差异均无统计学意义(P均> 0.05).三级医院入门-溶栓时间≤30 min的比例低于二级医院[46.4%(84/181)比62.2% (153/246),P=0.001],两者入门-球囊扩张时间≤90 min的比例差异无统计学意义[58.8% (60/102)比57.1% (4/7),P=1.000].三级和二级医院STEMI患者的住院病死率差异无统计学意义[5.8% (51/886)比5.5% (44/800),P=0.820].结论 河南省STEMI住院患者早期再灌注比例较低,溶栓是主要的早期再灌注方式;三级医院没有发挥其介入治疗的优势;二、三级医院在早期再灌注治疗上有很大的提高空间. Objective To observe the early reperfusion therapy status for patients with ST elevation acute myocardial infarction (STEMI) hospitalized in tertiary and secondary hospitals in Henan province.Methods Baseline data, early reperfusion treatment and in-hospital mortality of STEMI patients hospitalized in 17 hospitals in Henan province (8 tertiary hospitals, 9 secondary hospitals) from June 2011 to June 2012 were obtained using a uniformed questionnaire.Results One thousand six hundred and eighty six patients were enrolled, of which 886 patients were hospitalized in tertiary hospitals and 880 patients were early hospitalized in secondary hospitals.Six hundred and fifty four patients (38.8%, 654/1 686) underwent early reperfusion therapy (543 with thrombolysis and 111 with primary percutaneous coronary intervention (PCI)).There was no difference in the proportion of early reperfusion therapy between tertiary and secondary hospitals (40.1% (355/886) vs.37.4% (299/800), P =0.257).The median time from symptom onset to first medical contact, door-to-needle and door-to-balloon was 132 min, 18 min and 60 min, respectively.The median time from symptom onset to first medical contact (150 min vs.120 min, P =0.001), door-to-needle (30 min vs.18 min, P =0.003) and symptom onset-to-thrombolysis (3.5 h vs.2.7 h, P =0.001) were significantly longer in tertiary hospitals than in secondary hospitals.No difference was found in median time of door-to-balloon, symptom onset-to-primary PCI or symptom onset-to-elected PCI between tertiary and secondary hospitals (all P 〉0.05).The proportion of door-to-needle≤30 min was lower in tertiary hospitals than in secondary hospitals (46.4% (84/181) vs.62.2% (153/246), P =0.001).However, there was no difference in the proportion of door-to-balloon ≤90 min between tertiary and secondary hospitals (58.8% (60/102) vs.57.1% (4/7), P =1.000).In-hospital mortality was also similar between tertiary and secondary hospitals (5.8% (51/886) vs.5.5% (44/800), P =0.820).Conclusions Early reperfusion rate is low, and thrombolysis is the main early reperfusion therapy in both tertiary and secondary hospitals in Henan province.Tertiary hospitals did not take advantage of their primary PCI capability.There is great room for improvement in early reperfusion therapy in tertiary and secondary hospitals.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2015年第10期858-862,共5页 Chinese Journal of Cardiology
基金 河南省科技厅重点攻关项目(132102310080)
关键词 心肌梗死 心肌再灌注 数据收集 Myocardial infarction Myocardial reperfusion Data collection
  • 相关文献

参考文献12

  • 1O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST -elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundationl American Heart Association Task Force on Practice Guidelines[J]. Circulation,2013, 127 (4) :529-555.
  • 2Steg PG,James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation[J]. Eur HeartJ ,2012 ,33 (20) :2569- 2619.
  • 3无.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志,2015,43(5):380-393. 被引量:2388
  • 4Steg PG, Goldberg RJ, GoreJM, et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE)[J]. AmJ Cardiol,2002 ,90 (4) :358-363.
  • 5Widimsky P, Wijns W, FajadetJ, et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries[J]. Eur HeartJ, 2010 , 31 (8) :943-957.
  • 6Zhang SY, Hu DY, Sun YH, et al. Current management of patients with ST elevation myocardial infarction in Metropolitan Beijing, China[Jl. Clin Invest Med, 2008,31 (4) :EI89-197.
  • 7王硕仁,刘红旭,赵冬,雷燕,王薇,尚菊菊,房玉涛,史载祥,黄毅,李清朗,无.北京地区1242例急性心肌梗死患者住院治疗状况调查[J].中华流行病学杂志,2006,27(11):991-995. 被引量:53
  • 8Thygesen K, AlpertJS, White HD,et al. Universal definition of myocardial infarction[J]. Eur HeartJ, 2007 , 28 ( 20 ) : 2525- 2538.
  • 9于丽天,朱俊,Rebecca Mister,章晏,李建冬,王多劳,刘力生,Marcus Flather.我国部分医院ST段抬高急性冠状动脉综合征再灌注治疗登记研究[J].中华心血管病杂志,2006,34(7):593-597. 被引量:30
  • 10刘群,赵冬,刘军,王薇,刘静.中国ST段抬高急性冠状动脉综合征诊疗现况调查[J].中华心血管病杂志,2009,37(3):213-217. 被引量:49

二级参考文献29

  • 1于丽天,朱俊,Rebecca Mister,章晏,李建冬,王多劳,刘力生,Marcus Flather.我国部分医院ST段抬高急性冠状动脉综合征再灌注治疗登记研究[J].中华心血管病杂志,2006,34(7):593-597. 被引量:30
  • 2Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coil Cardiol, 2004,44: 671-719.
  • 3Smith SC Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation, 2006, 113 : 2363-2372.
  • 4Hasdai D, Behar S, Wallentin L, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the mediterranean basin. The survey of acute coronary syndromes. Eur Heart J, 2002, 23:1190- 1201.
  • 5Carruthers KF, Dabbous OH, Flather MD, et al. Contemporary management of acute coronary syndromes : does the practice match the evidence? The global registry of acute coronary events (GRACE). Heart, 2005, 91: 290-298.
  • 6Peterson ED, Roe MT, Mulgund J, et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA, 2006, 295: 1912-1920.
  • 7饶克勤.中国卫生统计年鉴2005.北京:协和医科大学出版社,2006:3-15.
  • 8Newby LK, LaPointe NM, Chen AY, et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation, 2006, 113: 203-212.
  • 9Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction.重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验[J].中华心血管病杂志,2007,35(8):691-696. 被引量:46
  • 10Ryan TJ, Antman EM, Brooks NH,et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. J Am Coil Cardiol, 1999,34:890-911.

共引文献2506

同被引文献191

引证文献21

二级引证文献695

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部